Free Trial

Applied Therapeutics (APLT) SEC Filings & 10K Form

Applied Therapeutics logo
$9.01 +0.09 (+1.01%)
(As of 11/14/2024 ET)

Recent Applied Therapeutics SEC Filings

DateFilerForm TypeView
11/13/2024
3:15 PM
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by)
Applied Therapeutics (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
11/07/2024
6:30 AM
Applied Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
6:19 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:38 PM
Applied Therapeutics (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
10/31/2024
11:42 AM
Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SCHEDULE 13G/A
10/24/2024
1:02 PM
Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
Form SC 13G
08/23/2024
3:33 PM
Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:35 PM
Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:52 PM
Applied Therapeutics (Subject)
Shendelman Shoshana (Filed by)
Form SC 13D/A
08/14/2024
6:01 PM
Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2024
7:43 PM
Applied Therapeutics (Subject)
Shendelman Shoshana (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
6:08 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
6:13 AM
Applied Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/10/2024
3:29 PM
Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:25 PM
Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:12 PM
Applied Therapeutics (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:13 PM
Applied Therapeutics (Issuer)
SKYLER JAY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:17 PM
Applied Therapeutics (Issuer)
Kanter Stacy J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
5:45 PM
Alexandria Equities No. 7, LLC (Reporting)
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting)
Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:26 PM
Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
5:10 PM
Applied Therapeutics (Subject)
Hansard Adam (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
6:13 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:17 AM
Applied Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/25/2024
11:15 PM
Applied Therapeutics (Filer)
Form EFFECT
04/25/2024
3:33 PM
Applied Therapeutics (Filer)
Form 424B3
04/22/2024
3:37 PM
Applied Therapeutics (Filer)
Form DEF 14A
04/22/2024
3:38 PM
Applied Therapeutics (Filer)
Form DEFA14A
04/22/2024
3:39 PM
Applied Therapeutics (Filer)
Form ARS
04/15/2024
4:27 PM
Applied Therapeutics (Issuer)
Hooks Corwin Dale (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/15/2024
4:30 PM
Applied Therapeutics (Issuer)
Hooks Corwin Dale (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
4:00 PM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
3:41 PM
Applied Therapeutics (Filer)
Form PRE 14A
03/22/2024
3:31 PM
Applied Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/18/2024
4:57 PM
Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
5:00 PM
Applied Therapeutics (Issuer)
Hansard Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
5:02 PM
Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
5:12 PM
Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:49 PM
Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2024
4:51 PM
Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:42 PM
Applied Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)

Cash In On the Pro-Crypto America 27 experts reveal their top picks for 2025

Click here to reserve your seat at the Crypto Community Summit.
03/11/2024
7:17 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
2:17 PM
Applied Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
03/06/2024
6:19 AM
Applied Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2024
6:12 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
4:42 PM
Applied Therapeutics (Subject)
Shendelman Shoshana (Filed by)
Form SC 13D/A
02/29/2024
3:18 PM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
1:26 PM
Applied Therapeutics (Subject)
Propel Bio Management, LLC (Filed by)
Form SC 13G/A
02/15/2024
6:07 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
8:20 PM
Applied Therapeutics (Subject)
Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
02/14/2024
5:30 PM
Applied Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/14/2024
3:22 PM
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by)
Applied Therapeutics (Subject)
Form SC 13G/A
02/14/2024
1:40 PM
Applied Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G/A
02/14/2024
12:50 PM
Alyeska Investment Group, L.P. (Filed by)
Applied Therapeutics (Subject)
Form SC 13G/A
02/09/2024
7:35 AM
Applied Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/06/2024
7:49 AM
Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G/A
01/03/2024
8:15 AM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
3:23 PM
Applied Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
7:01 PM
Applied Therapeutics (Issuer)
Hansard Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
7:01 PM
Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
7:01 PM
Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2023
11:29 AM
Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
Form SC 13G/A
12/06/2023
3:15 PM
Applied Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
12/05/2023
6:03 PM
Applied Therapeutics (Issuer)
Kanter Stacy J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
6:42 PM
Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
6:42 PM
Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
6:42 PM
Applied Therapeutics (Issuer)
Hansard Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
5:53 PM
Alexandria Equities No. 7, LLC (Reporting)
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting)
Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
3:41 PM
Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:APLT) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners